Group 1 - Zhongyuan Expressway (600020) expects a net profit of approximately 612 million yuan for 2025, a decrease of about 30% year-on-year [1] - Bomin Electronics (603936) anticipates a net profit of 15 million to 22 million yuan for 2025, achieving a turnaround from loss to profit compared to the previous year [2] - Fangda Special Steel (600507) forecasts a net profit of 835 million to 998 million yuan for 2025, an increase of 236.9% to 302.67% year-on-year [3] Group 2 - Jiadu Technology (600728) expects a net profit of 160 million to 200 million yuan for 2025, recovering from a loss of 115 million yuan in the previous year [4] - Changyang Technology (688299) predicts a net loss of 116 million to 168 million yuan for 2025 [5] - Zhongzi Technology (688737) anticipates a net loss of 45.24 million to 67.86 million yuan for 2025 [6] Group 3 - Two-sided Needle (600249) expects a net profit of 5 million to 10 million yuan for 2025, a decline of 87.67% to 93.83% year-on-year [7] - Sanrenxing (605168) forecasts a net profit of 181 million to 209 million yuan for 2025, an increase of 46.79% to 69.5% year-on-year [8] - Shubeide (300322) anticipates a net profit of 60 million to 70 million yuan for 2025, recovering from a loss of 64.46 million yuan in the previous year [9] Group 4 - Maoye Commercial (600828) expects a net loss of 201 million to 242 million yuan for 2025 [10] - Hongsheng Huayuan (601096) forecasts a net profit of 348 million to 400 million yuan for 2025, an increase of 51.22% to 73.82% year-on-year [11] - Huafeng Technology (688629) anticipates a net profit of 338 million to 388 million yuan for 2025, achieving a turnaround from loss to profit [12] Group 5 - Aerospace Rainbow (002389) expects a net profit of 25 million to 31 million yuan for 2025, a decrease of 64.84% to 71.65% year-on-year [14] - Shangong Shenbei (600843) predicts a net loss of 120 million to 150 million yuan for 2025, compared to a loss of 244 million yuan in the previous year [15] - Chaoxun Communication (603322) anticipates a net profit of 36 million to 54 million yuan for 2025, achieving a turnaround from loss to profit [16] Group 6 - Guannong Co. (600251) expects a net profit of 330 million to 340 million yuan for 2025, an increase of 61.29% to 66.18% year-on-year [17] - Shandong Steel (600022) forecasts a net profit of around 100 million yuan for 2025, recovering from a loss of 2.891 billion yuan in the previous year [18] - Baili Technology (603959) anticipates a net loss of 140 million to 200 million yuan for 2025 [19] Group 7 - Electric Power Investment Hydropower (600292) expects a net profit of approximately 517 million yuan for 2025, a year-on-year increase of about 1337% [20] - Aibulu (301259) forecasts a net profit of 26 million to 33.8 million yuan for 2025, recovering from a loss of 30.84 million yuan in the previous year [21] - Yipin Hong (300723) announced that its subsidiary received approval for clinical trials of a new drug [22] Group 8 - Meixin Sheng (688458) plans to acquire 100% equity of Xinyan Micro for 160 million yuan [23][24] - Lanshi Heavy Industry (603169) expects a net loss of 370 million to 440 million yuan for 2025, transitioning from profit to loss [25] - Hongyang (000525) anticipates a net loss of 260 million to 390 million yuan for 2025, compared to a profit of 388 million yuan in the previous year [26] Group 9 - Tianzhihang (688277) predicts a net loss of 165 million to 198 million yuan for 2025, with losses expected to widen by 36.22% to 63.46% compared to the previous year [27] - Tongda Co. (002560) announced plans for a major shareholder to reduce holdings by no more than 1% [28] - *ST Chengchang (001270) expects a net profit of 95 million to 124 million yuan for 2025, recovering from a loss of 31.12 million yuan in the previous year [29] Group 10 - Yirui Technology (688301) reported a net profit of 661 million yuan for 2025, a year-on-year increase of 42.15% [30] - Hualitai (001217) anticipates a net loss of 28 million to 38 million yuan for 2025, transitioning from profit to loss [31] - Yunjiji Group (001288) expects a net profit of 220 million to 252 million yuan for 2025, a year-on-year increase of 40% to 60% [32] Group 11 - Heertai (002402) forecasts a net profit of 638 million to 729 million yuan for 2025, an increase of 75% to 100% year-on-year [33] - Shenhao Technology (300853) anticipates a net loss of 185 million to 220 million yuan for 2025, compared to a loss of 238 million yuan in the previous year [34] - Zhongyan Dadi (003001) expects a net profit of 10 million to 15 million yuan for 2025, a decline of 75.97% to 83.98% year-on-year [35] Group 12 - Landai Technology (002765) forecasts a net profit of 180 million to 200 million yuan for 2025, a year-on-year increase of 44.83% to 60.93%, with a non-recurring profit of 140 million to 160 million yuan, an increase of 113.1% to 143.54% [37] - Yingfeite (300582) plans to raise product prices by 5% to 15% starting March 1, 2026, due to rising raw material costs [38] - Lanzhou Bank (001227) plans to distribute 285 million yuan in cash dividends for the 2025 interim profit distribution [39] Group 13 - Wancheng Group (300972) announced plans for shareholders to reduce holdings by no more than 1.27% [40] - *ST Huarong (600421) expects to turn a profit in 2025, with a projected net profit of 6.5 million to 8 million yuan [41] - Jiaheng Home (300955) anticipates a net loss of 29 million to 39 million yuan for 2025, compared to a loss of 23.69 million yuan in the previous year [42] Group 14 - Aide Biology (300685) announced plans for a major shareholder to reduce holdings by no more than 1.22% [43] - Haixia Innovation (300300) expects a net profit of 100 million to 150 million yuan for 2025, a year-on-year increase of 1660.56% to 2540.85% [44]

Summary of Key Points Core Viewpoint - Multiple shareholders across various companies are planning to reduce their holdings, indicating potential shifts in investor sentiment and market dynamics [1]. Shareholder Reductions - **Wancheng Group**: Shareholders Peng Dejian and his spouse Fan Hongjuan plan to reduce their holdings by up to 1.2 million shares [1]. - **Tianyang Technology**: Chairman and General Manager Ouyang Jianping intends to reduce his stake by no more than 3% [1]. - **Sudavige**: Shareholder Yu Zhangxing plans to reduce his holdings by up to 1.99% [1]. - **Aide Biology**: Shareholder Xiamen Keying intends to reduce holdings by up to 1.22% [1]. - **Kanshe Shares**: Multiple shareholders plan to collectively reduce their holdings by no more than 2.59% [1]. - **Bozhong Precision**: Shareholder Xinke Hongchuang plans to reduce holdings by up to 4.4665 million shares [1]. - **Zhonggang Luonai**: Shareholder Guo Xin Shuangbai Yihua plans to reduce holdings by 3.3065 million shares [1]. - **Matrix Technology**: Director and senior manager Cui Ling plans to reduce holdings by up to 300,000 shares [1]. - **Hongchang Technology**: Shareholder Jinhua Honghe plans to reduce holdings by no more than 0.33% [1]. - **Meixin Sheng**: Shareholder WI Harper Fund VII plans to reduce holdings by 1% [1]. Other Notable Information - **ST Xinchao**: The company’s stock may face delisting [1]. - **Changjiang Investment**: The stock may be subject to delisting risk warnings [1].

Important Market News - The Federal Reserve decided to maintain the federal funds rate target range at 3.5% to 3.75%, aligning with market expectations, with a vote of 10 in favor and 2 against [1] - U.S. stock indices closed mixed, with the Dow Jones up 0.02%, Nasdaq up 0.17%, and S&P 500 down 0.01%. Notable gains were seen in storage stocks, with Seagate Technology rising over 19%, Western Digital over 10%, and SanDisk over 9% [1] - European major indices all fell, with Germany's DAX down 0.29%, France's CAC40 down 1.06%, and the UK's FTSE 100 down 0.52% [1] Industry Insights - China Aerospace Science and Technology Corporation emphasized the importance of 2026 for commercial rocket development, aiming to enhance capabilities in space access and commercial launches [3] - The satellite internet sector is projected to reach between 200 billion to 400 billion yuan by 2030, with an annual compound growth rate of 10%-28%. This sector is transitioning from "concept validation" to "scale application" [3] - The "HuanTian Satellite Constellation Construction Project" has an estimated budget of 1.2 billion yuan for developing 22 remote sensing microsatellites, enhancing capabilities for rapid data acquisition and transmission [4] - DeepSeek launched a new document recognition model, DeepSeek-OCR2, which is expected to impact the global AI market significantly, as AI applications accelerate towards practical implementation [5][6]

Core Viewpoint - On January 28, no A-share listed companies disclosed any increase in shareholding, while nine companies announced share reductions, indicating a trend of shareholder divestment in the market [1]. Group 1: Share Reduction Details - Tongda Co., Ltd. plans to reduce its shareholding by no more than 1.00% [2] - Hongqi Chain's shareholder Yonghui Supermarket has reduced its stake by 0.79% [2] - Wancheng Group's shareholders intend to collectively reduce their holdings by no more than 1.27% [2] - Hongchang Technology's shareholders plan to reduce their holdings by no more than 0.33% [2] - Tianyang Technology's controlling shareholder Ouyang Jianping intends to reduce his stake by no more than 3% [2] - Aide Biology's shareholder Xiamen Keying plans to reduce its holdings by no more than 1.22% [2] - Juzitech's director and executive Cui Cen intends to reduce his stake by no more than 0.11% [2] - Bozhong Precision's shareholder Xinke Chuang plans to reduce its holdings by no more than 1% [2] - Tianyang's controlling shareholder Guolian Group intends to reduce its stake by no more than 1% [2]

Group 1: Industrial and Financial Performance - Industrial Fulian expects a net profit of 35.1 billion to 35.7 billion yuan for 2025, representing a year-on-year increase of 51% to 54% [1] - The company anticipates a net profit of 12.6 billion to 13.2 billion yuan in Q4 2025, an increase of 4.5 billion to 5.1 billion yuan compared to the same period last year, reflecting a growth of 56% to 63% [1] - Keda Xunfei forecasts a net profit of 785 million to 950 million yuan for 2025, with a year-on-year growth of 40% to 70% driven by the scaling of AI applications [2] Group 2: Industry Developments - Industrial Fulian's revenue from 800G high-speed switches is expected to grow by 13 times year-on-year in 2025, with Q4 revenue increasing over 4.5 times [1] - Keda Xunfei's large model projects achieved the highest number and amount of bids in the industry, totaling 2.316 billion yuan, surpassing the combined total of the second to sixth places [2] - Xiaocheng Technology anticipates a net profit of 90 million to 130 million yuan for 2025, a growth of 93.32% to 179.24% due to increased gold production and sales [4] Group 3: Risk and Challenges - Zhongshe Co. expects a negative net profit for 2025, which may lead to a risk warning for delisting due to low revenue [3] - Changjiang Investment forecasts a net profit of negative 30 million to negative 45 million yuan, also indicating potential delisting risks [12] - Macromedia's net profit is projected to decline by 65.61% to 72.48% for 2025, with Q4 performance below expectations [12]

格隆汇1月28日丨艾德生物(300685.SZ)公布，股东厦门科英投资合伙企业（有限合伙）计划在本减持计 划公告之日起三个交易日后的三个月内以大宗交易和集中竞价的方式减持公司股份，减持数量不超过 4,775,100股（占公司总股本的1.22%）。 ...

（记者 曾健辉） 每经AI快讯，艾德生物1月28日晚间发布公告称，持公司股份约1594万股的股东厦门科英投资合伙企业 （有限合伙），计划在本减持计划公告之日起三个交易日后的三个月内，以大宗交易和集中竞价的方式 减持公司股份，减持数量不超过约478万股。 每经头条（nbdtoutiao）——从极寒测试到万套装车！半固态电池今年有望搭载多款新车：各大厂商摩 拳擦掌，动力电池技术迎来迭代年 ...

艾德生物公告，持股1594.09万股占4.08%的股东厦门科英拟自公告后三个交易日起3个月内，通过大宗 交易和集中竞价减持不超477.51万股，占1.22%；任意连续90日内集中竞价减持不超1%，大宗交易减持 不超2%，价格按届时市场价确定。 ...

南财智讯1月28日电，艾德生物公告，持公司股份15,940,946股（占公司总股本的4.08%）的股东厦门科 英投资合伙企业（有限合伙）计划在本减持计划公告之日起三个交易日后的三个月内，以大宗交易和集 中竞价方式减持公司股份，减持数量不超过477.51万股（占公司总股本的1.22%）。 ...

证券代码：300685 证券简称：艾德生物 公告编号：2026-002 厦门艾德生物医药科技股份有限公司 关于特定股东减持计划的预披露公告 股东厦门科英投资合伙企业（有限合伙）保证向本公司提供的信息内容真实、 准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 1、股东厦门科英投资合伙企业（有限合伙）不是公司控股股东、实际控制人，本次减 持计划实施不会影响公司治理结构和持续经营，不会导致公司控制权发生变更。 2、持公司股份15,940,946股（占公司总股本1的4.08%）的股东厦门科英投资合伙企业（有 限合伙）计划在本减持计划公告之日起三个交易日后的三个月内以大宗交易和集中竞价的方 式减持公司股份，减持数量不超过4,775,100股（占公司总股本的1.22%）。 厦门艾德生物医药科技股份有限公司（以下简称"公司"或"艾德生物"） 于近日收到股东厦门科英投资合伙企业（有限合伙）（以下简称"厦门科英"） 出具的《减持计划告知函》，现将具体情况公告如下： 二、减持计划的主要内容 一、股东的基本情况 股东名称 持有公司股份数量（股） 占总 ...